Seelos Therapeutics Inc logo

Seelos Therapeutics Inc

1
NAS:SEEL (USA)  
$ 0.60 -0.0393 (-6.15%) 01:56 PM EST
At Loss
Enterprise V:
$ 19.59M
Volume:
380.95K
Avg Vol (2M):
457.38K
Also Trade In:
Volume:
380.95K
At Loss
Avg Vol (2M):
457.38K

Business Description

Description
Seelos Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders.
Name Current Vs Industry Vs History
Cash-To-Debt 0.21
Equity-to-Asset -6.19
Debt-to-Equity -0.43
Debt-to-EBITDA -0.39
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -94.96
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 15.3
3-Year EPS without NRI Growth Rate 12.1
3-Year FCF Growth Rate 29.7
Name Current Vs Industry Vs History
5-Day RSI 41.75
9-Day RSI 34.74
14-Day RSI 35.54
6-1 Month Momentum % -83.67
12-1 Month Momentum % -95.17

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.14
Quick Ratio 0.14
Cash Ratio 0.08
Days Sales Outstanding 249.36

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -75.3
Shareholder Yield % -176.25

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 2.77
EV-to-EBIT -0.53
EV-to-EBITDA -0.53
EV-to-Revenue 24.25
EV-to-FCF -0.82
Earnings Yield (Greenblatt) % -188.68
FCF Yield % -291.22

Financials (Next Earnings Date:2024-05-10 Est.)

SEEL's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SEEL

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Seelos Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.808
EPS (TTM) ($) -13.73
Beta 1.07
Volatility % 137.7
14-Day RSI 35.54
14-Day ATR ($) 0.125889
20-Day SMA ($) 0.921635
12-1 Month Momentum % -95.17
52-Week Range ($) 0.3676 - 49.8
Shares Outstanding (Mil) 13.68

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Seelos Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Seelos Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Seelos Therapeutics Inc Frequently Asked Questions

What is Seelos Therapeutics Inc(SEEL)'s stock price today?
The current price of SEEL is $0.60. The 52 week high of SEEL is $49.80 and 52 week low is $0.37.
When is next earnings date of Seelos Therapeutics Inc(SEEL)?
The next earnings date of Seelos Therapeutics Inc(SEEL) is 2024-05-10 Est..
Does Seelos Therapeutics Inc(SEEL) pay dividends? If so, how much?
Seelos Therapeutics Inc(SEEL) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1